Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk-adjusted Outpatient Salvage Therapy for Relapsed/Refractory Lymphoma
NCT00163761Phase 2Completed
- Start
- Dec 2002
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of vinorelbine and gemcitabine in non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) (2 arms). Primary endpoint: Overall Response Rate. Started Dec 2002; status: completed.
02
Drugs
vinorelbinegemcitabine
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00163761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163761.